BlackRock Investment Management’s Neos Therapeutics, Inc NEOS Stock Holding History

BlackRock Investment Management’s Portfolio NEOS Stock Details NEOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$300K	Hold	51,273	–	–	﹤0.01%	3164
2016 Q3	$337K	Sell	51,273 -113	-0.2%	-$895	﹤0.01%	3157
2016 Q2	$477K	Buy	51,386 +30,915	+151%	+$295K	﹤0.01%	3090
2016 Q1	$221K	Buy	20,471 +556	+3%	+$5.87K	﹤0.01%	3140
2015 Q4	$285K	Buy	19,915 +587	+3%	+$8.85K	﹤0.01%	3170
2015 Q3	$406K	Buy	+19,328	New	+$426K	﹤0.01%	3098

Other funds holding NEOS

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

BlackRock Investment Management's NEOS Position: Q4 2016 in Review

BlackRock Investment Management held its Neos Therapeutics, Inc (NEOS) position steady in Q4 2016 at 51,273 shares worth $300K. The position accounts for ﹤0.01% of the portfolio, ranked #3164.

BlackRock Investment Management first reported a position in NEOS in Q3 2015 and has held it in 6 quarters since. The position peaked at $477K in Q2 2016. 52 funds tracked by Wall St. Rank hold NEOS as of Q4 2016.

BlackRock Investment Management held 51,273 shares of Neos Therapeutics, Inc worth $300K as of Q4 2016.
BlackRock Investment Management left its Neos Therapeutics, Inc share count unchanged in Q4 2016.
Neos Therapeutics, Inc made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3164 holding.
BlackRock Investment Management first reported a position in Neos Therapeutics, Inc in Q3 2015 and has held it in 6 quarters since.
BlackRock Investment Management's Neos Therapeutics, Inc position peaked at $477K in Q2 2016.
52 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.